Search results “Clinical oncology options”
New Options for Lung Cancer Therapies
Dr. Joel Neal, a Stanford Cancer Institute researcher and oncologist, discussed clinical research on lung cancer therapies with a focus on immunotherapy and other targeted approaches.
Views: 6724 Stanford Health Care
Clinical Oncology MSc/Postgraduate Diploma - Full-time
Video introduced by Dr Jean Assender (Programme Lead). This course is for health care professionals from diverse backgrounds who wish to expand their knowledge of theoretical and practical aspects of oncology, this full-time programme is particularly suitable for medical professionals with an interest in clinical, medical, surgical and translational oncology.
Understanding the Basics of Clinical Oncology from Diagnosis to Treatment
(Visit: http://www.uctv.tv/) Dr. Andrew Ko, UCSF Comprehensive Cancer Center, provides definitions and terms used in cancer diagnosis and treatment. He explores the process of diagnosis from biopsies to imaging and how staging is established. He also discusses the multimodality approach to treatment which typically includes surgical oncology, medical oncology and radiation oncology. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [10/2013] [Health and Medicine] [Show ID: 25630]
An academic career in clinical oncology
Yee Pei Song talks about her academic career in clinical oncology. Findout more about a career in clinical oncology: http://bit.ly/2p50GHF
1. How to choose colleges for MD Radiotherapy courses ? 2.How should a young post graduate proceed after taking MD RT ? 3.Does Radiotherapist have risk of Radiation Exposure ? 4. New advancements in RT ? 5.Does Radiation Oncologist have to depend Hospital ?
Solving practical problems facing 3BP delivery in clinical oncology - Video asbtract [ID 170564]
Video abstract of an expert opinion paper "Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience" published in the open access International Journal of Nanomedicine by Salah Mohamed El Sayed. Abstract: 3-Bromopyruvate (3BP) is a promising powerful general anticancer agent. Unfortunately, 3BP release faces many practical and biochemical problems in clinical human oncology, for example, 3BP induces burning venous sensation (during intravenous infusion) and rapid inactivation by thiol groups of glutathione and proteins. 3BP exhibits resistance in glutathione-rich tumors without being able to exert selective targeting. 3BP does not cross the blood–brain barrier and cannot treat nervous system tumors. Importantly, 3BP cannot persist in tumor tissues due to the phenomenon of enhanced permeability and retention effect. Here, the author presents the practical solutions for clinical problems facing 3BP use in clinical oncol¬ogy, based on over 10 years of experience in 3BP research. Crude (unformulated 3BP that is purchased from chemical companies without being formulated in liposomes or other nanocar¬riers) should not be administered in clinical oncology. Instead, 3BP is better formulated with liposomes, polyethylene glycol (PEG), PEGylated liposomes (stealth liposomes) or perillyl alcohol that are used currently with many chemotherapeutics for treating clinical tumors in cancer patients. Formulating 3BP with targeted liposomes, for example, with folate, transfer¬rin or other ligands, improves tumor targeting. Formulating 3BP with liposomes, PEG, stealth liposomes or perillyl alcohol may improve its pharmacokinetics, hide it from thiols in the cir¬culation, protect it from serum proteins and enzymes, prevent burning sensation, prolong 3BP’s longevity and facilitate crossing the BBB. Formulating 3BP with stealth liposomes protects 3BP from the reticuloendothelial cells. Liposomal 3BP formulations may retain 3BP better inside the relatively large tumor capillary pores (abolish enhanced permeability and retention effect) sparing normal tissues, facilitate new delivery routes for 3BP (eg, topical and intranasal 3BP administration using perillyl alcohol) and improve cancer cytotoxicity. Formulating 3BP may be promising in overcoming many obstacles in clinical oncology. Read the expert opinion paper here: https://www.dovepress.com/enhancing-anticancer-effects-decreasing-risks-and-solving-practical-pr-peer-reviewed-article-IJN
Views: 203 Dove Medical Press
New Options for Gastrointestinal Cancer Therapies
Dr. George A. Fisher, a Stanford Cancer Institute researcher and oncologist, discussed clinical research on gastrointestinal cancer therapies with a focus on immunotherapy. Two clinical trial participants shared their experiences.
Integrating Clinical Research and Clinical Oncology Around Patients
Jay (Marty) Tenenbaum is the founder and chairman of Cancer Commons, a nonprofit network of patients, physicians and scientists that identifies the best options for treating an individual’s cancer then refines the community’s collective knowledge based on each patient’s response. He is a computer scientist, internet commerce pioneer and cancer survivor.
Lung Cancer | Dr. Grace Dy | Clinical Oncology Year in Review
Roswell Park Comprehensive Cancer Center's Chief of Thoracic Oncology, Dr. Grace Dy, presents data relating to lung cancer at the Clinical Oncology Year in Review meeting that was hosted at Roswell Park in November of 2018.
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2018
Our panel of immunotherapy experts discusses the latest cancer immunotherapy advances featured at the world’s largest oncology conference—the 2018 annual meeting of the American Society of Clinical Oncology (ASCO)—with topics including combination immunotherapy, biomarker development, CAR T cell therapies, and new approaches to immune-based cancer treatment. Panelists include Charles G. Drake, M.D., Ph.D., of NewYork-Presbyterian/Columbia University Medical Center, and Catherine Diefenbach, M.D., and Jeffrey S. Weber, M.D., of the Perlmutter Cancer Center at NYU Langone Health. Jill O'Donnell-Tormey, Ph.D., of the Cancer Research Institute, moderates. We present this video as part of the Answer to Cancer patient and caregiver education program of the Cancer Research Institute, and feature it as part of our sixth annual global awareness campaign, Cancer Immunotherapy Month, in June. This panel was recorded on June 4, 2018, in Chicago, IL.
Surgical Oncology for Gastrointestinal Cancer  - Mayo Clinic
Barbara A. Pockaj, M.D., Richard J. Gray, M.D., and Nabil Wasif, M.D. -- the surgical oncology team at Mayo Clinic in Arizona -- present the latest surgical options for gastrointestinal cancer diagnoses.
Views: 5177 Mayo Clinic
Advances in Cancer Immunotherapy™ – SITC Regional Education Programs
Find an upcoming Advances in Cancer Immunotherapy™ (ACI) program at http://www.sitcancer.org/aci. Advance your oncology career, earn CE credit and learn about current cancer immunotherapy treatment options for your patients during an ACI program. The ACI series, developed by the Society for Immunotherapy of Cancer (SITC), is targeted to clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians, allied health professionals, students and patient advocates.
Developments in neoadjuvant immunotherapy options for early-stage lung cancer patients
Dr Luis Raez speaks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about exciting developments in lung cancer treatment from this year's meeting. Dr Raez also provides his insight into the exciting developments in lung cancer treatment featured in this year's meeting, including the update on the LCMC study which uses atezolizumab both in the neoadjuvant and adjuvant setting. Dr Raez also speaks about the results from the NEOSTAR trial, which combined immunotherapeutic agents nivolumab and ipilimumab in the neoadjuvant setting. Dr Raez said the development of neoadjuvant options for early-stage lung cancer patients, as well as trials combining immunotherapy with chemotherapy, provides a very promising landscape for the future of lung cancer treatments.
Views: 78 ecancer
Understanding Systemic Chemotherapy Options in Bladder Cancer | Part I: Clinical Decision Making
In Part I of IV "Understanding Systemic Chemotherapy Options in Bladder Cancer" Patient Insight Webinar, Dr. Jean Hoffman-Censits from Sidney Kimmel Cancer Center at Jefferson discusses the various considerations taken to determine a patient's chemotherapy treatment plan.
Immunotherapy: A Look at the Year Ahead for 2019
2018 was a big year for cancer immunotherapy. In addition to several approvals of checkpoint immunotherapies for new cancer types, combinations strategies involving these treatments were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. https://www.cancerresearch.org/events/webinars Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. In this webinar for patients and caregivers, Elizabeth M. Jaffee, M.D., covers these remarkable immunotherapy breakthroughs from the past year and discusses the field’s ongoing efforts to overcome the challenges ahead and enable immunotherapy to benefit even more people with cancer. Elizabeth M. Jaffee, M.D., currently works at Johns Hopkins University in Baltimore, where she holds many prestigious positions, including serving as the deputy director of the Sidney Kimmel Comprehensive Cancer Center, the associate director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, the Dana and Albert “Cubby” Broccoli professor of oncology, co-director of gastrointestinal cancer and diseases program, and co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care. Outside of Johns Hopkins, Dr. Jaffee also currently serves as the chair of the National Cancer Advisory Board for the National Cancer Institute, the co-chair of the National Cancer Institute Blue Ribbon Panel for the National Cancer Moonshot Initiative, the leader of the Stand Up To Cancer-Lustgarten Foundation Pancreatic Cancer Dream Team, and the president of the American Association for Cancer Research, among other roles. Dr. Jaffee has received numerous awards in recognition of her contributions, including the AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research in 2015 and the Johns Hopkins University Office of Women in Science and Medicine Vice Dean’s Award in 2012. She is a member of the Cancer Research Institute Scientific Advisory Council. The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is hosted by our science writer, Arthur Brodsky, Ph.D. The 2019 series is made possible with generous support from Bristol-Myers Squibb and Cellectis. Browse our Cancer Immunotherapy and You Webinar Series playlist on YouTube or visit the Webinars page on our website to see other webinars in this series. https://www.cancerresearch.org/events/webinars
CAR T-cell Therapy: A Hopeful Option in Cancer Treatment (Full Video)
The Leukemia & Lymphoma Society (LLS) invites patients and caregivers to learn more about: • CAR T-cell therapy as an emerging treatment option • The impact of clinical trials in the advancement of treatment for blood cancer patients Please provide your feedback after viewing the video. Visit http://www.LLS.org/educationvideos to access additional patient education videos. For disease, treatment and support information, please call an LLS Information Specialist at (800) 955-4572 or email [email protected] For LLS patient education programs, please visit http://www.LLS.org/programs. For professional education programs, visit http://www.LLS.org/professionaled. We hope you find this program informative and helpful. Support for this video provided by Juno Therapeutics, Kite Pharma, and Novartis Oncology.
Medical Oncology Updates for Lung Cancer
NYU Langone medical oncologist Dr. Joshua Sabari discusses a new era of treatment options for lung cancer. Learn more about Dr. Sabari: https://nyulangone.org/doctors/1356638894/joshua-k-sabari Learn more about NYU Langone’s Perlmutter Cancer Center: http://nyulangone.org/locations/perlmutter-cancer-center
Views: 1057 NYU Langone Health
Ovarian cancer: Mayo Clinic Radio
Dr. Kristina Butler, a Mayo Clinic gynecologic oncologist, discusses diagnosing and treatment options for ovarian cancer. This interview originally aired July 13, 2019. Learn more about ovarian cancer: https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/symptoms-causes/syc-20375941?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.181280679.1058927920.1562587815-165526356.1480776015
Views: 457 Mayo Clinic
Immunotherapy and Triple Negative Breast Cancer - Mayo Clinic
A promising new study from Mayo Clinic, in conjunction with Caris Life Sciences, points to immunotherapy as a possible treatment option for patients with the difficult-to-treat triple negative breast cancer mutation. The study was presented this week at the 50th annual meeting of the American Society of Clinical Oncology in Chicago. "This study may change our ability to treat triple negative breast cancer patients," says Barbara Pockaj, M.D., lead investigator of the study and Mayo Clinic surgeon. "We may have signs that these patients can be treated with immunotherapy. We don't have a lot of options for these patients and this would really expand our options."
Views: 6555 Mayo Clinic
Immunotherapy Options in CRC
Pashtoon M. Kasi, MD, MBBS, MS, an assistant professor of oncology and senior associate consultant in the Division of Hematology/Oncology at the Mayo Clinic, discusses the patient populations with colorectal cancer (CRC) that are likely to benefit from immunotherapy treatment. Previously, immunotherapy was not an option for patients with CRC, but now a subset of patients has been identified that responds to this type of treatment, Kasi says. Patients categorized with mismatch repair deficient, microsatellite instability-high, or Lynch syndrome-associated CRC make up the subset of patients who respond to immunotherapy. For a subset of patients, immunotherapy agents such as anti-PD-1 inhibitors and the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) have been approved by the FDA. Kasi explains that while this is not the majority of patients with CRC, all patients should be checked for these biomarkers as immunotherapy can be a very viable option. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/resource-center/colorectal
Views: 105 Targeted Oncology
Pocket Guide to Radiation Oncology
Designed to fit easily in your lab coat or scrubs, Pocket Guide to Radiation Oncology is an efficient, no-frills guide to the basics of clinical radiation oncology. The chapters are packed with clinical pearls and tables covering treatment options, doses, side effects, target delineations, treatment planning, and other essentials. Chapters are organized by site-specific disease. Each chapter presents the must-know key points, including treatment options by stage, relevant technical considerations, and important items for follow-ups.
Pancreatic Cancer Clinical Trials NYC | Weill Cornell Medicine Gastrointestinal Oncology Program
https://weillcornell.org/gicancer Given the severity of his pancreatic cancer diagnosis, Peter Rosow felt he needed more than just the standard chemotherapy treatment another center had recommended. After a trusted friend, who also happened to be a doctor, told Peter to reach out to Dr. Ruggiero at Weill Cornell Medicine’s Gastrointestinal (GI) Oncology Program, Peter sought him out. Dr. Ruggiero and the Weill Cornell GI Oncology team were able to offer Peter access to more cutting-edge treatment options that were not widely available, and he enrolled in the pancreatic cancer clinical trial that saved his life. Under Dr. Ruggiero’s care and expertise, and as a result of the clinical trial, Peter’s tumor shrank. After some additional sessions of radiation, the tumor completely disappeared. Three and a half years after his initial diagnosis, Peter “feels fine”. More importantly, he says, “I’m still here.” Call us now at 646-962-6200, or click the link below to learn more: https://weillcornell.org/gicancer Pancreatic Cancer Clinical Trials NY Pancreatic Cancer Center NYC Pancreatic Cancer Chemotherapy NYC Pancreatic Cancer Treatment Pancreatic Cancer Options Pancreatic Cancer Research 1305 York Ave., 12th floor New York, NY 10065 Related Videos: https://youtu.be/_vJIfMOFbqw https://youtu.be/Yfrvy29Kb4U https://youtu.be/UpxrHepz1gc I was diagnosed with pancreatic cancer in December of 2011. I was diagnosed at another major cancer New York center. And I was told at the time that I had about a year to live, and they offered me the standard chemotherapy treatment. Given the seriousness of my problem, I felt that I wanted and needed more than just the standard treatment. A very good friend of the family, who was a physician, encouraged me strongly to go to Dr. Ruggiero at Weill Cornell, because he was dealing with a brand new pancreatic cancer therapy, that had just been reported out literally within the last few months from a clinical study in France, with excellent results. So that's how I got to Dr. Ruggiero and Weill Cornell. The studies that we've done and the care that we've provided over the past couple of years has rather dramatically improved survival for these, you know, fairly common and often very difficult to treat cancers. It allows us to provide cutting edge therapies that are not yet generally available. And that's really essential in cancer therapies. The objective was to shrink this tumor sufficient so it could be removed surgically. The tumor shrunk, I had the surgery, but it could not be removed. It was too tangled up with blood vessels and things. I then had 27 radiation treatments, and at the end the tumor was gone. It's been three and a half years since my diagnosis and I feel fine, and I'm still here. For more info, click this link: https://youtu.be/Yfrvy29Kb4U https://www.google.com/#tbm=vid&q=Pancreatic+Cancer+Clinical+Trials+NY Video production, video search engine optimization and video marketing provided by Video SEO Pro, Inc. To learn more give us a call at (914) 368-9600 or click the link below. http://www.myvideoseopro.com/lp001
High-Risk Advanced Ovarian Cancer: Chemotherapy Options
Considerations of chemotherapeutic options for patients with advanced ovarian cancer and a high-risk of recurrence. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 13 Targeted Oncology
Clinical Data and Third-Line Options for CLL
John F. Gerecitano, MD, PhD, describes the therapeutic management of the patient with chronic lymphocytic leukemia, including the clinical data for venetoclax, and the options for third-line therapy. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 121 Targeted Oncology
Stomach Cancer Clinical Trials NY | Weill Cornell Medicine Gastrointestinal Oncology Program
https://weillcornell.org/gicancer Jonathan Lowenberg sought out stomach cancer clinical trials when he was diagnosed with a tumor in his GI junction. He wanted to choose a cancer treatment center that could not only offer phenomenal treatment options, but a doctor and hospital with a great reputation, and who would be understanding of his unique needs as a patient. When Dr. Manish Shah, Medical Director at the Weill Cornell Medicine Gastrointestinal (GI) Oncology Program, offered Jonathan the option to participate in a clinical trial, he accepted immediately, as Weill Cornell had a long history of successful and groundbreaking research and clinical trials. Within 11 weeks his stage 3 cancer was completely gone. According to Jonathan, the personalized care and treatment he received led to results that were “amazing and quite extraordinary.” He considers Dr. Shah and the GI cancer team at Weill Cornell Medicine to have given him “a second act.” Call us now at 646-962-6200, or click the link below to learn more: https://weillcornell.org/gicancer Stomach Cancer Clinical Trials NYC Stomach Cancer Center NY Stomach Cancer Chemotherapy NYC Stomach Cancer Treatment Stomach Cancer Options Stomach Cancer Research 1305 York Ave., 12th floor New York, NY 10065 Related Videos: https://youtu.be/hhX-bDgLZtU https://youtu.be/oSrDqvs-jck https://youtu.be/eOU9tPcurqs You know it's shock I mean any time you find out something like this, where you literally are told that you have a stage three cancer. I was just in complete shock. My choice, when I did get my bearings together, was to pick someone who had a great reputation. Someone who was going to be understanding of the patient, and who was actually going to look at me as a person. It's like family. I mean this is a institution that when you go through something so serious like cancer, they make you feel like a family here. When the patient comes and sees us, they really feel that they are individually taken care of. Our goal is to give people the best opportunity for the best outcomes with the best promotion of health. So I was on a standard regimen of chemotherapy, but then Doctor Shah asked me if I would participate in the clinical trial that Weill Cornell was sponsoring with NIH, and I didn't even hesitate. The entire cancer was gone after 11 weeks. It's amazing, it's quite extraordinary. Manish Shah and his incredible team at Weill Cornell have given me a second act, and an act that I don't take lightly. Walk through Central Park every day now and look at every tree, and every flower that blooms, and it has a different aura for me. For more info, click this link: https://youtu.be/oSrDqvs-jck https://www.google.com/#tbm=vid&q=Stomach+Cancer+Clinical+Trials+NY Video production, video search engine optimization and video marketing provided by Video SEO Pro, Inc. To learn more give us a call at (914) 368-9600 or click the link below. http://www.myvideoseopro.com/lp001
Sidewalks to Science Webinar: Integrating Genomic "Big Data" & Clinical Oncology in Breast Cancer
The Susan G. Komen "Sidewalks to Science" webinar in June was led by Dr. Daniel G. Stover, Assistant Professor of Internal Medicine in the Medical Oncology Division at Ohio State University. He focused on the integration of genomic data and Clinical Oncology in the world of breast cancer.
Views: 51 The 3-Day
Breast Cancer Medical Oncology: Your Consultation
We teach what you will cover with your breast cancer medical oncologist. Learn about chemotherapy, hormonal therapy, and cutting-edge treatment options. VISIT THE BREAST CANCER SCHOOL FOR PATIENTS: http://www.breastcancercourse.org LIST OF QUESTIONS FOR YOUR DOCTORS: http://www.breastcancercourse.org/breast-health-updates-latest-videos/ FOLLOW US: Facebook: https://www.facebook.com/Breast-Cancer-School-for-Patients-958519147618444/ _____________________________________ What is a medical oncologist? Your medical oncologist is a critical member of your breast cancer team. By the time you meet with an oncologist, you most likely have seen a breast surgeon and may have had your tumor removed by surgery. The goal with your medical oncologist is to work together to tailor a treatment plan with medications (hormonal medications, chemotherapy, and immunotherapy) that specifically targets your unique breast cancer and prevents it from ever coming back. Your medical oncologist will be with you for as long as 10 years, so it’s critical to find a medical oncologist you can trust. What can you learn from your medical oncologist? A medical oncologist can add to the knowledge you have already gained from your breast surgeon and online research. He or she should teach you about the “biology” of your unique tumor and the best treatment options for you and your cancer. Understanding this information is critical for you to be able to make the best treatment decisions. The Breast Cancer School for Patients helps with your medical oncology consultation in a unique way. We have completed the difficult task of organizing the vast field of breast cancer into one, patient-friendly site. We teach you to be a breast cancer “expert” and give you the key questions to ask your medical oncologist to make sure you get cutting-edge cancer care in your community. Do you work with a “Multidisciplinary Team?” Ask your medical oncologist if he or she regularly participates in a breast cancer multidisciplinary team. These breast cancer teams are usually associated with breast centers accredited by the National Accreditation Program for Breast Centers (NAPBC). The most sophisticated breast cancer treatment originates from a detailed discussion of your breast cancer situation with many specialists. These brainstorming sessions specifically about you can improve your treatment options and outcome. Can cutting-edge advances in oncology be lifesaving? The greatest lifesaving advances in breast cancer care are in the field of medical oncology. The overarching goal of cutting-edge research is to improve outcomes and lessen side effects of treating cancer. You must learn about these advances and specifically ask your medical oncologist if they are appropriate for your breast cancer situation. Our short video lessons at the Breast Cancer School for Patients www.breastcancercourse.org will teach you how to bring these options into your discussions with your medical oncologist. Take our lessons that cover topics like: Would a genomic assay help determine if I need or can avoid chemotherapy? What are the new drugs to treat “HER2 Positive” breast cancers? Do I qualify for BRCA genetic testing? Would I benefit from a clinical trial? Engage your medical oncologist with questions The Breast Cancer School for Patients helps you engage your medical oncologist. We teach you with short video lessons exactly what will be discussed so you can quickly become an expert in breast cancer treatment. You will be asked to make important treatment decisions quickly. Print out our course notes with the key questions to make sure you are offered the best treatment choices. We educate you so you can engage and work as a team with your breast cancer specialists. Get informed before speaking with your breast cancer medical oncologist. Register for our newsletter and “Cutting-Edge” questions Sign-up for our breast health newsletter at www.breastcancercourse.org. Once registered, we’ll immediately email you our complete list of “cutting-edge” questions to engage your breast surgeon, medical oncologist, and radiation oncologist. We help you get quality breast cancer care in your community.
Gastrointestinal Cancer Clinical Trials NY | Weill Cornell Medicine Gastrointestinal Oncology
https://weillcornell.org/gicancer Anne Glauber is on the road to recovery from her grim pancreatic cancer diagnosis after receiving phenomenal treatment through a gastrointestinal cancer clinical trial that she underwent at Weill Cornell Medicine. Initially, another doctor at another hospital gave Anne only one year to live. Unwilling to accept this prognosis, Anne was determined to find the best pancreatic cancer doctors in the United States and she was particularly looking for doctors that would give her access to innovative, cutting-edge treatments, as well as compassionate care. After much research, Anne and her family sought out Dr. Allyson Ocean at the Gastrointestinal (GI) Oncology Program at Weill Cornell Medicine. On every level, Anne was given personalized, individualized treatment at Weill Cornell, and she’s now back on the road to living a healthy, normal life. Call us now at 646-962-6200, or click the link below: https://weillcornell.org/gicancer Colon Cancer Clinical Trials NYC Colon Cancer Center NYC Colon Cancer Chemotherapy NY Colon Cancer Treatment Colon Cancer Options Colon Cancer Research 1305 York Ave., 12th floor New York, NY 10065 Related Videos: https://youtu.be/iEdEZ7toinM https://youtu.be/YHkH85BBrg4 https://youtu.be/c8cfbUuc3Tc I was diagnosed a year ago. We went to another hospital, not here. And a surgeon read my CAT scans and said to me, "Your situation's very bad. Your pancreatic cancer has spread to the liver. I give you a year to live." And I was there with my entire family. I turned to them, and we said, "We're not going to listen to this guy's advice at all." Following that advice, I went and did my research and went to find the best pancreatic cancer doctors in the country. And what I was particularly looking at, and looking for, were not doctors that were going to give me a standard treatment, but pancreatic cancer doctors who were willing, now, to be as innovative and creative as they possibly can be. I think a patient should choose Weill Cornell to receive their care for gastrointestinal cancers, because not only do we deliver the highest standard of care, the most cutting edge research, but we also deliver the best care. I never feel like I'm getting anything typical. I always feel like I'm getting personal, individualized treatment on every level. Through my protocol, through the science that stands behind this treatment, and then through Allyson Ocean's own personality. Her kindness, her graciousness, her willingness to respond immediately to any questions, not only from me, but from my family as well. I just passed my one year diagnosis. My cancer has regressed. My tumor markers are really low. I'm feeling very well, a normal life when the surgeon last year told me I would have none. That's what it means to come to Weill Cornell. I could have a normal life. For more info, click this link: https://youtu.be/YHkH85BBrg4 https://www.google.com/#tbm=vid&q=Gastrointestinal+Cancer+Clinical+Trials+NY Video production, video search engine optimization and video marketing provided by Video SEO Pro, Inc. To learn more give us a call at (914) 368-9600 or click the link below. http://www.myvideoseopro.com/lp001
Gastric Cancer Surgical Treatment Options
Debbie's Dream Foundation: Curing Stomach Cancer 2015 Chicago Stomach Cancer Education Symposium Presented by: Mitchell C. Posner, MD, FACS, University of Chicago
Why Should I Consider a Cancer Clinical Trial?
http://www.learnaboutclinicaltrials.org - This video from the ACT (About Clinical Trials) program features patients and doctors who share their perspectives on why joining a cancer clinical trial may be an option worth considering at any point in ones' cancer journey.
Views: 1030 Genentech
Breast Cancer Clinical Trials: Should I Participate?
FWe teach you how to locate clinical trials for breast cancer. Participating in clinical trial research can help you and others get better breast cancer care in the future. VISIT THE BREAST CANCER SCHOOL FOR PATIENTS: http://www.breastcancercourse.org LIST OF QUESTIONS FOR YOUR DOCTORS: http://www.breastcancercourse.org/breast-health-updates-latest-videos/ FOLLOW US: Facebook: https://www.facebook.com/Breast-Cancer-School-for-Patients-958519147618444/ __________________________ Questions for your Breast Cancer Physicians: 1. Do you participate in clinical trials for breast cancer? 2. Would a clinical trial offer me new treatment options? 3. What are the risks of participating in a clinical trial? 4. Where is the closest institution that participates in clinical trials? 5. What is a clinical trial? Any new cancer drug, device, or treatment needs to be studied to make sure it is safe and effective. Every breast cancer drug, such as tamoxifen or chemotherapy, must complete the clinical trial process before being approved by the Food and Drug Administration (FDA) for cancer treatment. New devices for surgery and radiation also go through this complex process. Less than 5% of all patients with cancer are enrolled in clinical trials. Patients with cancer willing to participate in clinical trials are essential for the advancement of cancer care. All treatment options available for patients today are based on the generous participation of others in breast cancer clinical trials. Who may benefit from participating? Newer treatment advances may be available only through clinical trials. Many of these new therapies will not prove to be better than current treatments, but some will. Participating in a clinical trial may give you the opportunity to benefit from these new therapies. Patients who have more advanced stage cancer (inflammatory breast cancer or stage III and IV cancers) usually have more clinical trial options. These cancers are the most worrisome and threatening. Many new treatments are first studied with those who have advanced cancer. It is worth inquiring with your breast specialists about clinical trials if you have advanced stage cancer. Another active area of research involves “triple negative” and “HER2-positive” breast cancer. Many clinical trials are trying to find better therapies for these more aggressive cancers. Clinical trials are also available for early stage breast cancer. The majority women diagnosed with breast cancer have Stage I or II disease. These early stage trials involve surgical techniques, chemotherapy, hormonal therapy, immunotherapy, and radiation therapy. Sharing your time to advance breast cancer care can be a rewarding experience during a difficult time. What are the possible risks of participating? Clinical trials require a personal commitment of time and effort during a stressful time. Before participating, make sure you have the personal and emotional resources for your own breast cancer treatment journey. “Adverse Events” with new treatments can result in harm. Although there is risk with any cancer treatment, the risks with new treatments are not as well known. Some seek clinical trials for their unique cancer situation. Others are asked to participate in clinical trials by their physicians. Make sure you are willing and able to participate if you are asked. You can always say “No” to participating. Make sure you do not feel pressured into entering a clinical trial by your breast cancer team. Patient-Friendly References: lbbc.org This excellent brochure (here) “Guide to Understanding Breast Cancer Treatment Research Studies” is a good overview. Living Beyond Breast Cancer is a non-profit organization dedicated to providing quality information about breast cancer to patients. cancer.net This online resource (here) “Clinical Trials” is a comprehensive database to research clinical trials in breast cancer. The American Society of Clinical Oncology is a leading organization of physicians that care for those with cancer. breastcancertrials.org This resource can introduce you to breast cancer clinical trials across the country. It has an online, personalized matching tool that can help find a clinical trial for your unique cancer situation. More Detailed References: fda.gov There are excellent resources (here) “FDA Drug Approval Process Infographic” from the Food and Drug Administration. cancer.net This detailed site (here) outlines information in video and text format about clinical trials and how to find clinical trials in cancer. The American Society of Clinical Oncologists is a leading organization of clinicians who care for people living with cancer.
Treatment Options for Early Stage Breast Cancer
http://www.beetmedicine.tv/2009/06/treatment-options-for-early-stage-breast-cancer.html Hormone therapy is used in all stages of estrogen receptor positive breast cancer. The success of five years of Tamoxifen in post menopausal women has been augmented by the addition of Aromatase inhibitors. Dr. Rugo describes the randomized clinical trials designed to determine the duration and sequencing of hormones and the different approaches required in pre and post menopausal women. Also, the emerging role of biphosphonates, a non-hormonal, non-chemotherapy approach to strengthening bone and preventing metastases. Interviewee: Hope S. Rugo, MD, Clinical Professor of Medicine; Director, Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center Hope Rugo
Views: 3048 BeetMedicineTV
Treating Cancer with Clinical Trials - Cancer Center of Santa Barbara
Cancer is a devastating disease, but at the Cancer Center of Santa Barbara with Sansum Clinic we work hard to provide the best cancer care to everyone we can. We treat patients with a wide range of cancers, sometimes with the help of clinical trials. A clinical trial is a comparison between standard treatment and a new treatment that may prove to be better. Clinical trials are vital to the evolution of cancer treatment.Today's standard practices were all proven by clinical trials before they became widely available. The most important aspect of clinical trials is that it affords access to the newest drugs available. For information on clinical trials and other cancer treatment options visit our website at http://www.sansumclinic.org/oncology-hematology
Views: 252 Sansum Clinic
The Future of Prostate Cancer Research and Treatment
YouTube Live Thursday, January 12, 2017 2:30 - 3:30pm ET Prostate cancer experts William Dahut, M.D. of the National Cancer Institute and Dr. Heather Cheng, M.D. of the University of Washington discuss current and future research areas and treatment options for prostate cancer. The panel was moderated by Ana Fadich, MPH, CHES Vice President at Men’s Health of the Men's Health Network. http://www.cancer.gov/prostate http://www.cancer.gov/social-media/events
The value of oncology clinical trials
Clinical trials are the backbone of cancer research. In this video, Willamette Valley Cancer Institute medical oncologist Dr. Marc Uemura discusses clinical trials and how they are offering many patients new options and hope. Learn more about clinical trials at WVCI here: https://bit.ly/2Ictt4K
Bladder Cancer Treatment NY | Weill Cornell Medicine Genitourinary Oncology Program
https://weillcornell.org/gucancer The Genitourinary (GU) Oncology Program at Weill Cornell Medicine is one of the leading centers for bladder cancer treatment in the United States and throughout the world. At Weill Cornell Medicine, New York’s premier healthcare network, we offer cancer patients innovative bladder cancer treatment options, including clinical trials. Additionally, the Genitourinary Oncology Program utilizes a multidisciplinary approach to deliver care in a supportive environment so that patients not only receive exceptional medical advice, but compassionate and comprehensive care. We integrate the latest scientific developments in our research and treatment practices, and offer access to social services, nutritional guidance, support groups, genetic counseling and more. The GU Oncology Program also uses precision medicine to create unique, customized cancer treatments based on a patient’s genetic profile. Should medical complications arise that require hospitalization, you will always be in great hands through our partnership with NewYork-Presbyterian Hospital, the 7th best hospital in the country according to the 2015-2016 U.S. News and World Report. If you are in need of a cutting-edge, personalized treatment for bladder cancer, the Genitourinary (GU) Oncology Program at Weill Cornell Medicine is simply unmatched. Call us now at (646) 962-2072, or click the link below to learn more: https://weillcornell.org/gucancer Prostate Cancer Treatment NY Prostate Cancer Treatment New York City Kidney Cancer Treatment NYC Kidney Cancer Treatment New York City Bladder Cancer Treatment NYC Bladder Cancer Treatment New York City 525 East 68th Street New York, NY 10065 Related Videos: https://youtu.be/zqiXeqInvhc https://youtu.be/54S1lyiJH60 https://youtu.be/224x9zpY4gU I was very surprised to get the news. Oh, boy. I've got Stage IV prostate cancer. But the question wasn't 'What is it that I have?' The question was 'What am I going to do about it?' At Weill Cornell we have a very strong program in genitourinary cancers. That includes prostate cancer, bladder cancer, kidney cancer, and testicular cancer. We also have really across the board top line medical specialties that's all here within one roof. It's very important to be connected to a hospital, such as New York Presbyterian. We have a great faculty that's at our disposal. It's a multi-disciplinary team. Not only the medical oncologists, but we also work very closely with our radiation oncology colleagues, our urology surgeons, from pathologists to radiologists. So whenever we see a new patient, we present the patient at a tumor board. And at that tumor board there's the whole gamut of physicians involved in care. What makes us unique is our dedication to research. And when I say research, not only laboratory research within the cancer center, but clinical research. We have our own clinical trials. I think the benefits from participating in clinical trials from the patient point of view is multi-factorial. Sometimes there's access to a drug that otherwise would not be available. Some of these are very promising, and we know today that there have been improvements in almost every cancer that there is through clinical trials. Some patients have the misconception that clinical trials are for the very end. That's not true. Clinical trials are for every stage or state of your cancer. One of the great things that we have at Weill Cornell is our Institute for Precision Medicine. As a team we've really been highly focused on precision medicine, and this is really an approach to try to identify which patients might respond the most effectively to the available therapies that we have. We do this by looking oftentimes at the molecular alterations in their cancers. Coming up with treatments that are targeting that defect and be able to treat patients with more personalized treatments rather than treating everyone the same. I'm not a number. I'm a person. And because of precision medicine, I'm here today. For more info, click this link: https://youtu.be/VETm3qGVsD8 https://www.google.com/?gws_rd=ssl#tbm=vid&q=Bladder+Cancer+Treatment+NY Video production, video search engine optimization and video marketing provided by Video SEO Pro, Inc. To learn more give us a call at (914) 368-9600 or click the link below. http://www.myvideoseopro.com/lp001
Pancreatic Cancer Immunotherapy Clinical Trials at Penn Medicine: Moving Beyond Chemotherapy
Pancreatic cancer is a leading cause of cancer-related death in the United States. At Penn Medicine, our doctors and researchers are taking action to create more options and better strategies for pancreatic cancer treatment. The Penn Pancreatic Research Center is attacking this problem from multiple angles. Our team includes nationally-recognized oncologists, scientists, surgeons, gastroenterologists and pathologists, all working together to create personalized treatment plans from the most advanced therapies available, including clinical trials. Clinical trials are state-of-the-art therapies, such as immunotherapy, that extend pancreatic cancer treatment beyond chemotherapy, surgery and radiation. Our clinical trials are designed to provide what we call “hope for all stages.” We also offer support for people working through the often scary time following diagnosis. Our team includes a talented nurse navigator to guide patients through every phase of care. The Penn Pancreatic Research team shares one mission: to turn pancreatic cancer into a chronic, treatable illness. “Our outcomes are better not just because our treatments are better, but because our care is better.” - Ursina Teitelbaum, MD, Clinical Director of the Pancreatic Cancer Research Center Learn more about pancreatic cancer: https://www.pennmedicine.org/cancer/types-of-cancer/pancreatic-cancer See what Penn's Pancreatic Cancer Program offers: https://www.pennmedicine.org/cancer/navigating-cancer-care/programs-and-centers/pancreatic-cancer-program Find clinical trials for all phases of pancreatic cancer: https://www.pennmedicine.org/cancer/navigating-cancer-care/programs-and-centers/pancreatic-cancer-program/pancreatic-cancer-tce Find a pancreatic cancer clinical trial: https://app.emergingmed.com/acc-upenn/trials/ #PancreaticCancer #Immunotherapy #PennMedicine
Views: 732 Penn Medicine
Clinical Oncology Centre ( Sazzy Falak)
What is Cancer? Cancer is a large, heterogeneous class of diseases in which a group of cells display uncontrolled growth, invades and destroys (near by) tissues, and often metastasizes (spread) via the lymphatic system or through the bloodstream. These three malignant properties of cancer differentiate it from benign tumors, which do not grow uncontrollably, invades locally, or metastasize.
Novel Surgical Options – Brian Badgwell, MD, MD Anderson Cancer Center
Debbie's Dream Foundation hosted its 5th Stomach Cancer Education Symposium on Saturday, April 18, 2015 for in person attendees and via live webinar. Over 175 patients, families, caregivers, the general public, and health care professionals attended for free. Speakers and topics included: Stomach Cancer Patients & Caregivers Panel Integrative Medicine & Nutritional Considerations – Kathleen Mary Wesa, MD Novel Surgical Options – Brian Badgwell, MD, MD Anderson Cancer Center Non-Surgical Treatment Options – Richard Kim, MD, Moffitt Cancer Center Genomics – Adam Bass, MD, Harvard Dana-Farber Cancer Institute Clinical Trials – Edith P. Mitchell, MD, FACP, Thomas Jefferson University Radiation Oncology – Lawrence R. Kleinberg, MD, Sidney Kimmel Cancer Institute at Johns Hopkins
Care Oncology - Your hope is in our care.
Care Oncology provides COC Protocol as an adjunct treatment for conventional cancer therapies. COC Protocol has undergone 4-years of clinical testing. The early results of the study has shown that use of the protocol in combination with an existing treatment may increase therapeutic effect. Clinical data also suggests that COC Protocol may double patient survivability when incorporated as adjunctive therapy. We are undertaking ongoing studies both in the UK and US into how COC Protocol may complement and enhance standard of care therapy. Medications used in the patented COC Protocol are well understood and have long histories of safety and reliability. For more information, visit www.careoncology.com Music: "Cassini" by Thomas Wyman https://soundcloud.com/teedub-3
Views: 1059 Care Oncology
Immunotherapy clinical trials
Dr. Evan Yu discusses the novel treatment option clinical trials provide at Seattle Cancer Care Alliance, particularly those in immunotherapy. Learn more about clinical trials active at SCCA: http://ow.ly/LGQo30ajoDD Subscribe to our channel: http://ow.ly/cw9B308MFsc
Latest in CRC: Findings from the 2017 ASCO Annual Meeting Webinar
We’ve had a record-breaking number of advances in colorectal cancer over the last year. The treatment and survivorship landscape has dramatically changed as the FDA approved new drugs and treatment options for patients.
Kidney Cancer Center NY | Weill Cornell Medicine Genitourinary Oncology Program
https://weillcornell.org/gucancer Dan Raiciulescu was in need of a premier kidney cancer center after he was diagnosed with clear cell carcinoma in his kidneys that had also spread to the lymph nodes of his lungs. Dan chose the expert team of doctors at the Weill Cornell Medicine Genitourinary (GU) Oncology Program for his treatment and felt that it quickly became like a second home. He shares that he was treated as though he was a family member and that this is one of the reasons why he holds the GU cancer program in such high regard. Additionally, Weill Cornell’s affiliation with NewYork-Presbyterian Hospital was lifesaving for Dan, as a lung specialist quickly treated a serious infection that he developed during his clinical trial. From the expert medical care Dan received, to the kindness he experienced from the staff, Dan reveals why he is so grateful for the Genitourinary (GU) Oncology Program at Weill Cornell Medicine. Call us now at (646) 962-2072, or click the link below to learn more: https://weillcornell.org/gucancer Kidney Cancer Clinical Trials NY Kidney Cancer Center NYC Kidney Cancer Chemotherapy NYC Kidney Cancer Treatment Kidney Cancer Options Kidney Cancer Research 525 East 68th Street New York, NY 10065 Related Videos: https://youtu.be/Vzfdr30A_K8 https://youtu.be/Xr87s3XtHFY https://youtu.be/9CYNvGDct4Y The type of cancer that I've been diagnosed is clear-cell carcinoma. It wasn't only the kidney. I have four lymph nodes on my lungs. It was a pretty bad phase of my cancer. From the very beginning, when you go to the check-in desk, you are like in a big family. It makes the blood pressure go down. Usually it's not that syndrome that you have when you're in the hospital and everything goes up, just because you know that you're in good hands and you're like at home, like a second home. This is what I think that is unique about this hospital. In my opinion, patients should choose Weill Cornell for their treatment for GU malignancies, in essence, because I truly feel that we have an excellent team. Not only the medical oncologists, there's four of us here, but we also work very closely with a great faculty at New York Presbyterian that's at our disposal for any complications that our patients may encounter while they're getting treatment for their cancer. Not too far ago, I had a real bad infection on one of the lungs. It was a pretty big one. And they told me if I waited three more days, I was...you know what I mean. Immediately Dr. Molina sent me to the lung doctor. He was great. They took good care of me. I took a bunch of antibiotics, and here I am. In the three months with the care that I received with the whole team of doctors and nurses and everybody else, I would encourage every patient to come over here. With open heart and open arms, they're going to be received over here. It's all I can tell everybody. God forbid, I don't wish this disease on anybody, not even to my enemies. But realistically speaking, if it hits you, this is a great hospital. For more info, click this link: https://youtu.be/9CYNvGDct4Y https://www.google.com/?gws_rd=ssl#tbm=vid&q=Kidney+Cancer+Center+NY Video production, video search engine optimization and video marketing provided by Video SEO Pro, Inc. To learn more give us a call at (914) 368-9600 or click the link below. http://www.myvideoseopro.com/lp001
Learn About Cancer Immunotherapy Clinical Trials – NYC Immunotherapy Patient Summit 2018
Brian Brewer breaks down many myths and facts about clinical trials at the 2018 Immunotherapy Patient Summit in New York City. cancerresearch.org/summit Brian Brewer provides a brief overview of clinical trial design, phases, common misconceptions, and vital questions that every patient should ask when considering a clinical trial. Cancer Research Institute Immunotherapy Patient Summits are free half-day Saturday events that provide a forum for patients, caregivers, and advocates to meet together along with scientific and healthcare experts to learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers. In 2018, the Immunotherapy Patient Summit series visits San Francisco, New York City, San Diego, and Houston. The New York City summit was live streamed online. This video is a recording of the live stream. cancerresearch.org/summit (c) Cancer Research Institute 2018
Bladder Cancer | Q&A
Surgeon, Armine Smith, from the Brady Urological Institute answers questions about bladder cancer, diagnosis and treatment options available. At the Greenberg Bladder Cancer Institute, cancer specialists work together to provide patients with expert care in radiation oncology, urologic surgery, medical oncology, radiology, pathology and research. These leading minds in cancer discuss each patient's case in detail to create a custom, groundbreaking treatment plan. Questions Answered: 1. How does bladder cancer form? 0:03 2. Are there specific risk factors for bladder cancer? 0:27 3. How is bladder cancer found? 0:44 4. What are the treatment options for bladder cancer? 1:27 5. What is the difference between muscle invasive and non-muscle invasive bladder cancer? 2:56 6. What are the different types of urinary diversions? 3:50 7. How is the diversion chosen? 4:28 8. Do all bladder cancer patients need surgery? 4:51 9. Why should I have bladder cancer treatment at Johns Hopkins 5:22
Views: 22471 Johns Hopkins Medicine
Antifungal Options for Oncology Patients -- Rod Quiliz, Pharm.D.
Dr. Quilitz reviews vital information about the use of antifungal medications in the treatment of fungal infections.
Views: 300 IDPodcasts